What is HC Wainwright’s Estimate for RIGL Q1 Earnings?
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL – Free Report) – Equities research analysts at HC Wainwright issued their Q1 2025 earnings estimates for Rigel Pharmaceuticals in a research report issued to clients and investors on Wednesday, March 5th. HC Wainwright analyst J. Pantginis anticipates that the biotechnology company will earn ($0.07) per share for the quarter. HC […]
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL – Free Report) – Equities research analysts at HC Wainwright issued their Q1 2025 earnings estimates for Rigel Pharmaceuticals in a research report issued to clients and investors on Wednesday, March 5th. HC Wainwright analyst J. Pantginis anticipates that the biotechnology company will earn ($0.07) per share for the quarter. HC […]
